An FDA panel comprised of independent experts has voted 11 to 8 against allowing the U.S. Navy to test emergency ...

The AP reports that states and communities around the nation are developing creative readiness strategies in preparation ...

A diagnostic device that resembles a mammography unit can detect breast tumors as tiny as one-fifth of an inch in ...

CryoLife Inc. has received CE Mark and Health Canada approval for a new rigid applicator tip for its BioGlue Surgical ...

A prospective clinical study shows that the GeneSearch Breast Lymph Node Assay, a gene-based diagnostic test, has greater sensitivity than traditional intra-operative methods of detecting the spread of breast cancer to the lymph nodes. In the study, sponsored by Veridex LLC, the GeneSearch demonstrated overall sensitivity at least 10 percentage points higher than intra-operative tests.

A Navy plan to test a blood substitute on civilian trauma victims should remain on hold, federal health advisers ...

Quest Diagnostics Inc. has introduced its newly developed test, the Breast Cancer Gene Expression Ratio, to help ...

During last year's influenza season, the number of infants and toddlers in the U.S. who were vaccinated against the flu ...

Breast cancer rates in the United States dropped dramatically in 2003, and experts attribute the sudden decline to the ...

GE Healthcare today released the results of Omega Management Group’s 3rd quarter survey of GE customers - a survey ...